Susquehanna International Group
FLNA

Susquehanna International Group’s Filana Therapeutics FLNA Stock Holding History

Susquehanna International Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$756K Sell
447,278
-80,740
-15% -$166K ﹤0.01% 8619
2025
Q4 		$1.05M Buy
528,018
+146,000
+38% +$467K ﹤0.01% 7084
2025
Q3 		$1.11M Sell
382,018
-64,412
-14% -$148K ﹤0.01% 7093
2025
Q2 		$808K Sell
446,430
-105,591
-19% -$188K ﹤0.01% 7985
2025
Q1 		$828K Buy
552,021
+271,628
+97% +$685K ﹤0.01% 7733
2024
Q4 		$662K Buy
280,393
+219,508
+361% +$3.85M ﹤0.01% 7978
2024
Q3 		$1.79M Sell
60,885
-630,039
-91% -$14.5M ﹤0.01% 5496
2024
Q2 		$8.53M Buy
690,924
+675,236
+4,304% +$14.2M ﹤0.01% 2693
2024
Q1 		$318K Sell
15,688
-1,458
-9% -$33.6K ﹤0.01% 9580
2023
Q4 		$386K Sell
17,146
-5,212
-23% -$110K ﹤0.01% 9270
2023
Q3 		$372K Sell
22,358
-158,921
-88% -$3.15M ﹤0.01% 8893
2023
Q2 		$4.44M Sell
181,279
-60,411
-25% -$1.45M ﹤0.01% 3729
2023
Q1 		$5.83M Buy
241,690
+161,810
+203% +$4.48M ﹤0.01% 3222
2022
Q4 		$2.36M Buy
79,880
+51,887
+185% +$1.86M ﹤0.01% 4419
2022
Q3 		$1.17M Sell
27,993
-28,073
-50% -$758K ﹤0.01% 6237
2022
Q2 		$1.58M Sell
56,066
-176,845
-76% -$4.47M ﹤0.01% 5408
2022
Q1 		$8.65M Sell
232,911
-26,827
-10% -$1.14M ﹤0.01% 2748
2021
Q4 		$11.3M Sell
259,738
-115,483
-31% -$6.06M ﹤0.01% 2551
2021
Q3 		$23.3M Buy
375,221
+23,735
+7% +$1.98M ﹤0.01% 1821
2021
Q2 		$30M Sell
351,486
-16,341
-4% -$875K ﹤0.01% 1602
2021
Q1 		$16.5M Buy
367,827
+12,142
+3% +$478K ﹤0.01% 2120
2020
Q4 		$2.43M Buy
355,685
+235,351
+196% +$2.1M ﹤0.01% 4700
2020
Q3 		$1.39M Buy
120,334
+16,156
+16% +$72.8K ﹤0.01% 5346
2020
Q2 		$321K Sell
104,178
-94,467
-48% -$428K ﹤0.01% 8238
2020
Q1 		$816K Buy
+198,645
New +$1.32M ﹤0.01% 5843
2019
Q4 		– Sell
-12,198
Closed -$15K – 10504
2019
Q3 		$15K Sell
12,198
-10,318
-46% -$13.3K ﹤0.01% 9982
2019
Q2 		$28K Sell
22,516
-41,899
-65% -$47.5K ﹤0.01% 9962
2019
Q1 		$83K Buy
64,415
+37,085
+136% +$42.5K ﹤0.01% 8314
2018
Q4 		$24K Buy
27,330
+15,460
+130% +$17.8K ﹤0.01% 8650
2018
Q3 		$12K Sell
11,870
-41
-0.3% -$62 ﹤0.01% 9036
2018
Q2 		$25K Sell
11,911
-107
-0.9% -$918 ﹤0.01% 9401
2018
Q1 		$85K Sell
12,018
-12,581
-51% -$84.9K ﹤0.01% 8760
2017
Q4 		$98K Buy
24,599
+12,574
+105% +$50.8K ﹤0.01% 8700
2017
Q3 		$49K Buy
12,025
+106
+0.9% +$379 ﹤0.01% 8542
2017
Q2 		$49K Buy
11,919
+5,947
+100% +$28.1K ﹤0.01% 8893
2017
Q1 		$37K Sell
5,972
-5,503
-48% -$25K ﹤0.01% 8635
2016
Q4 		$45K Buy
11,475
+3,223
+39% +$14.9K ﹤0.01% 9312
2016
Q3 		$58K Buy
+8,252
New +$137K ﹤0.01% 8084
2016
Q2 		– Sell
-1,999
Closed -$31K – 9221
2016
Q1 		$31K Buy
1,999
+294
+17% +$3.8K ﹤0.01% 8760
2015
Q4 		$21K Sell
1,705
-6,373
-79% -$84.3K ﹤0.01% 9216
2015
Q3 		$103K Sell
8,078
-25,365
-76% -$320K ﹤0.01% 9124
2015
Q2 		$405K Buy
33,443
+31,741
+1,865% +$435K ﹤0.01% 8019
2015
Q1 		$23K Sell
1,702
-2,778
-62% -$37.5K ﹤0.01% 9260
2014
Q4 		$64K Buy
+4,480
New +$77.6K ﹤0.01% 9313
2014
Q3 		– Sell
-17,976
Closed -$546K – 9873
2014
Q2 		$723K Sell
17,976
-1,435
-7% -$53.1K ﹤0.01% 6737
2014
Q1 		$747K Buy
19,411
+13,976
+257% +$493K ﹤0.01% 6040
2013
Q4 		$185K Sell
5,435
-662
-11% -$17.6K ﹤0.01% 8324
2013
Q3 		$116K Sell
6,097
-7,826
-56% -$137K ﹤0.01% 8029
2013
Q2 		$215K Buy
+13,923
New +$294K ﹤0.01% 7323

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Susquehanna International Group's FLNA Position: Q1 2026 in Review

Susquehanna International Group reduced its Filana Therapeutics (FLNA) stake by 15% in Q1 2026, selling an estimated $166K and leaving 447,278 shares worth $756K. The position accounts for ﹤0.01% of the portfolio, ranked #8619.

Susquehanna International Group first reported a position in FLNA in Q2 2013 and has held it in 49 quarters since. The position peaked at $30M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Susquehanna International Group held 447,278 shares of Filana Therapeutics worth $756K as of Q1 2026.
  • Susquehanna International Group sold 80,740 Filana Therapeutics shares in Q1 2026, an estimated $166K.
  • Filana Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8619 holding.
  • Susquehanna International Group first reported a position in Filana Therapeutics in Q2 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Filana Therapeutics position peaked at $30M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.